- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2156
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Search for genetic factors predisposing to atherogenic dyslipidemia ; volume:4 ; number:1 ; day:31 ; month:12 ; year:2003 ; pages:1-4 ; date:12.2003
BMC genetics ; 4, Heft 1 (31.12.2003), 1-4, 12.2003
- Creator
-
Yip, Agustín G.
- Contributor
-
Ma, Qianli
Wilcox, Marsha
Panhuysen, Carolien I.
Farrell, John
Farrer, Lindsay A.
Wyszynski, Diego F.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2156-4-S1-S100
- URN
-
urn:nbn:de:1111-2016041527544
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yip, Agustín G.
- Ma, Qianli
- Wilcox, Marsha
- Panhuysen, Carolien I.
- Farrell, John
- Farrer, Lindsay A.
- Wyszynski, Diego F.
- SpringerLink (Online service)
Other Objects (12)
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
Diabetes Dyslipidemia
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
Genetic factors predisposing high body weight and fatness in selected mouse lines
Identification of genetic risk factors predisposing to the inflammatory oral disease periodontitis
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
Diabetes Dyslipidemia
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
Genetic factors predisposing high body weight and fatness in selected mouse lines
Identification of genetic risk factors predisposing to the inflammatory oral disease periodontitis
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
Association between Atherogenic Dyslipidemia and Recurrent Stroke Risk in Patients with Different Subtypes of Ischemic Stroke
Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
Diabetes Dyslipidemia
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
Genetic factors predisposing high body weight and fatness in selected mouse lines